Omega Fund Management, LLC Q1 2025 Filing
Filed May 15, 2025
Portfolio Value
$169.5B
Holdings
13
Report Date
Q1 2025
Filing Type
13F-HR
All Holdings (13 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | KMTSKestra Med Technologies Ltd. | 1,795,893 | $44.8B | 26.41% | |
| 2 | BCAXBicara Therapeutics Inc. | 2,204,650 | $28.7B | 16.95% | |
| 3 | BBNXBeta Bionics Inc. | 1,988,287 | $24.3B | 14.36% | |
| 4 | NUVBNuvation Bio | 13,072,340 | $23.0B | 13.58% | |
| 5 | REPLReplimune Group | 1,975,203 | $19.3B | 11.36% | |
| 6 | UPBUpstream Bio Inc. | 2,036,293 | $12.5B | 7.35% | |
| 7 | LXEOLexeo Therapeutics | 1,184,636 | $4.1B | 2.43% | |
| 8 | ALMSAlumis Inc. | 653,223 | $4.0B | 2.37% | |
| 9 | —Ikena Oncology | 2,249,123 | $2.9B | 1.70% | |
| 10 | ENGNenGene Holdings Inc. | 526,357 | $2.4B | 1.39% | |
| 11 | IMUXImmunic Inc. | 1,788,160 | $1.9B | 1.15% | |
| 12 | SANASana Biotechnology, Inc. | 843,750 | $1.4B | 0.84% | |
| 13 | ENGNWenGene Holdings Inc. | 321,502 | $192.9M | 0.11% |